AlphaYouRAPP: Gault Cheryl discloses a sale
By AlphaYouPublished Form 4
Gault Cheryl
Reporting filer
Gault Cheryl reported Sale in Rapport Therapeutics, Inc.: 7925 units of Common Stock, dated 2026-09-30. The full Form 4 contains 2 transaction entries.
- Disclosed
- Oct 1, 2026
Reported details
2 entries| Security | Owner | Date | Code | Action | Quantity | Price | Following holdings | Reporting delay | Filed terms and references |
|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Gault Cheryl | 2026-09-30 | S | Sale | 7925 | 33.0364 | 141,989 | 1 day | Filed terms
|
| Common Stock | Gault Cheryl | 2026-09-30 | S | Sale | 2075 | 33.7556 | 139,914 | 1 day | Filed terms
|
Common Stock
- Owner
- Gault Cheryl
- Date
- 2026-09-30
- Code
- S
- Action
- Sale
- Quantity
- 7925
- Price
- 33.0364
- Following holdings
- 141,989
- Reporting delay
- 1 day
- Filed terms and references
Filed terms
- security Title: Common Stock
- transaction Date: 2026-09-30
- transaction Form Type: 4
- transaction Code: S
- equity Swap Involved: false
- id: F1
- transaction Shares: 7925
- transaction Price Per Share: 33.0364
- id: F2
- transaction Acquired Disposed Code: D
- shares Owned Following Transaction: 141989
- direct Or Indirect Ownership: D
Common Stock
- Owner
- Gault Cheryl
- Date
- 2026-09-30
- Code
- S
- Action
- Sale
- Quantity
- 2075
- Price
- 33.7556
- Following holdings
- 139,914
- Reporting delay
- 1 day
- Filed terms and references
Filed terms
- security Title: Common Stock
- transaction Date: 2026-09-30
- transaction Form Type: 4
- transaction Code: S
- equity Swap Involved: false
- id: F1
- transaction Shares: 2075
- transaction Price Per Share: 33.7556
- id: F3
- transaction Acquired Disposed Code: D
- shares Owned Following Transaction: 139914
- direct Or Indirect Ownership: D
Purchases, sales, grants and option exercises are different transactions. The reported code identifies the action; it does not establish a motive.
Filing context
- Quantities and prices are shown in the units filed. No trade value is inferred from their product.
- Gault Cheryl: Chief Operating Officer.
- The filing reports a Rule 10b5-1 trading plan.
- F1: These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on December 10, 2025.
- F2: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $32.64 to $33.62, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected.
- F3: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $33.64 to $34.00, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected.
Original sources
Prepared automatically from public filing data. Report a correction.